Anticonvulsant medication errors in children with epilepsy during the home-to-hospital transition

Charlotte Jones1, Megan Missanelli, Leon Dure

  • 1Department of Pediatrics, Division of Pediatric Neurology, The Ohio State University, Columbus, Nationwide Children's Hospital, Columbus, OH 43205, USA. Charlotte.Jones@Nationwidechildrens.org

Insights

Pediatric epilepsy patients frequently experience medication errors when transitioning to the hospital. Disruptions in anticonvulsant administration, especially changes in who gives the medicine, increase the risk of these common errors.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacy
  • Patient Safety

Background:

  • Children with epilepsy require consistent anticonvulsant therapy.
  • Transitions between home and hospital settings pose a risk for medication regimen disruption.

Purpose of the Study:

  • To determine the frequency of anticonvulsant medication errors in children with epilepsy during hospital admission.
  • To identify risk factors associated with these medication errors.

Main Methods:

  • Retrospective review of medical records for 120 children with epilepsy admitted for non-seizure related reasons.
  • Analysis of medication errors, categorized by dosing quantity or missed doses.
  • Multivariable modeling to assess risk factors for errors.

Main Results:

  • Twenty-nine out of 120 children (24%) experienced at least one anticonvulsant medication error.
  • Changes in administration responsibility and frequency of anticonvulsant administration were significantly associated with increased odds of errors.

Conclusions:

  • Anticonvulsant medication errors are common during the home-to-hospital transition for children with epilepsy admitted for non-seizure reasons.
  • Interventions targeting administration responsibility and scheduling may reduce medication errors.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...